US Patent 9018161 Protease resistant insulin analogues
Patent 9018161 was granted and assigned to Novo Nordisk on April, 2015 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 9018161 Protease resistant insulin analogues
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
